Professor Aron Popovtzer is the Director of the Sharett Institute of Oncology at Hadassah Medical Center, specializing in head and neck cancer and radiotherapy. With expertise in otolaryngology, radiation oncology, and medical oncology.
Co-Chair, Hadassah Cancer Research Institute
Chair, Sharret Institute of Oncology at Hadassah Medical Center
Associate Professor, Department of Oncology, Tel Aviv University
As Chair of the Sharrett Institute of Oncology at Hadassah Medical Center and Co-Chair of the Hadassah Cancer Research Institute in Jerusalem, I combine clinical expertise with innovative research to advance cancer treatment technologies.
125 published papers with 8000+ citations
Leading FDA-approved studies in alpha radiation therapy
€4 million+ in competitive research funding
10+ medical device and AI cancer treatment startups
Developing innovative cancer therapies through targeted radiation and nanoparticle technologies
Pioneer in "Alpha DaRT" technology development, using radioactive radium-224 for precise cancer treatment. Led multiple clinical trials and FDA approval studies for skin, head and neck cancers, with expanding applications in glioblastoma and pancreatic tumors.
Conducted groundbreaking research on antibody-conjugated gold nanoparticles as radiosensitizers, evaluating toxicity, biodistribution, and blood-brain barrier penetration in various cancer models.
Contributing to clinical development in biotechnology and medical device companies